Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 352

1.

Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis.

Adler Ma SC, Brindle W, Burton G, Gallacher S, Hong FC, Manelius I, Smith A, Ho W, Alston RP, Bhattacharya K.

J Cardiothorac Vasc Anesth. 2011 Feb;25(1):26-35. doi: 10.1053/j.jvca.2010.08.012. Epub 2010 Nov 5. Review.

PMID:
21115366
2.

A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting.

Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, Angelini GD.

J Thorac Cardiovasc Surg. 2006 Sep;132(3):475-80, 480.e1-8.

3.

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Innovations (Phila). 2012 Jul-Aug;7(4):229-41. doi: 10.1097/IMI.0b013e3182747699.

PMID:
23123988
4.

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Anesth Analg. 2012 Aug;115(2):239-43. doi: 10.1213/ANE.0b013e3182264a11. Epub 2011 Jul 7.

PMID:
21737704
5.

Does tranexamic acid reduce blood loss in off-pump coronary artery bypass?

Mehr-Aein A, Sadeghi M, Madani-civi M.

Asian Cardiovasc Thorac Ann. 2007 Aug;15(4):285-9.

PMID:
17664199
6.

Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery.

Taghaddomi RJ, Mirzaee A, Attar AS, Shirdel A.

J Cardiothorac Vasc Anesth. 2009 Jun;23(3):312-5. doi: 10.1053/j.jvca.2008.09.018. Epub 2008 Dec 21.

PMID:
19103500
7.

Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.

Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.

Anesth Analg. 2008 Nov;107(5):1469-78. doi: 10.1213/ane.0b013e318182252b.

PMID:
18931201
8.

Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.

Ker K, Edwards P, Perel P, Shakur H, Roberts I.

BMJ. 2012 May 17;344:e3054. doi: 10.1136/bmj.e3054. Review.

9.

Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.

Casati V, Della Valle P, Benussi S, Franco A, Gerli C, Baili P, Alfieri O, D'Angelo A.

J Thorac Cardiovasc Surg. 2004 Jul;128(1):83-91.

10.

Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aortic valve and coronary artery bypass graft surgery: a randomized controlled trial.

Greiff G, Stenseth R, Wahba A, Videm V, Lydersen S, Irgens W, Bjella L, Pleym H.

J Cardiothorac Vasc Anesth. 2012 Apr;26(2):232-8. doi: 10.1053/j.jvca.2011.07.010. Epub 2011 Sep 15.

PMID:
21924636
11.

Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).

Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, Brucek P, Maly M.

Eur J Cardiothorac Surg. 2005 Oct;28(4):563-8.

PMID:
16125959
12.

Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery.

Ahn SW, Shim JK, Youn YN, Song JW, Yang SY, Chung SC, Kwak YL.

Circ J. 2012;76(1):96-101. Epub 2011 Oct 28.

13.

Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis.

Abrishami A, Chung F, Wong J.

Can J Anaesth. 2009 Mar;56(3):202-12. doi: 10.1007/s12630-008-9038-x. Epub 2009 Feb 12. Review.

PMID:
19247741
14.

Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.

Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ.

Eur J Cardiothorac Surg. 2009 Aug;36(2):322-9. doi: 10.1016/j.ejcts.2008.11.038. Epub 2009 Feb 27.

PMID:
19250838
15.

Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting.

Jares M, Vanek T, Straka Z, Brucek P.

J Cardiovasc Surg (Torino). 2003 Apr;44(2):205-8.

PMID:
12813384
16.

Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?

Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S.

Anesthesiology. 2006 Nov;105(5):1034-46. Review.

PMID:
17065899
17.

Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer.

Kietpeerakool C, Supoken A, Laopaiboon M, Lumbiganon P.

Cochrane Database Syst Rev. 2016 Jan 23;(1):CD011732. doi: 10.1002/14651858.CD011732.pub2. Review.

PMID:
26801659
18.

Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: toward selective conservation strategies.

Arora RC, Légaré JF, Buth KJ, Sullivan JA, Hirsch GM.

Ann Thorac Surg. 2004 Nov;78(5):1547-54.

PMID:
15511428
19.

Tranexamic acid in total knee replacement: a systematic review and meta-analysis.

Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM.

J Bone Joint Surg Br. 2011 Dec;93(12):1577-85. doi: 10.1302/0301-620X.93B12.26989. Review.

PMID:
22161917
20.

Aprotinin and tranexamic acid for high transfusion risk cardiac surgery.

Wong BI, McLean RF, Fremes SE, Deemar KA, Harrington EM, Christakis GT, Goldman BS.

Ann Thorac Surg. 2000 Mar;69(3):808-16.

PMID:
10750765
Items per page

Supplemental Content

Write to the Help Desk